Cargando…

PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape

Ironically, population aging which is considered a public health success has been accompanied by a myriad of new health challenges, which include neurodegenerative disorders (NDDs), the incidence of which increases proportionally to age. Among them, Alzheimer’s disease (AD) and Parkinson’s disease (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uzuegbunam, Bright Chukwunwike, Librizzi, Damiano, Hooshyar Yousefi, Behrooz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070523/ https://www.ncbi.nlm.nih.gov/pubmed/32098280 http://dx.doi.org/10.3390/molecules25040977

Ejemplares similares

Clinical Relevance of [(18)F]Florbetaben and [(18)F]FDG PET/CT Imaging on the Management of Patients with Dementia
por: Librizzi, Damiano, et al.
Publicado: (2021)

Toward Novel [(18)F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils
por: Uzuegbunam, Bright C., et al.
Publicado: (2022)

In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker
por: Uzuegbunam, Bright C., et al.
Publicado: (2023)

Attenuation of neurological deficit by a novel ethanolamine derivative in rats after brain trauma
por: Sysoev, Yuriy Igorevich, et al.
Publicado: (2019)

Mapping the Binding Interface of PET Tracer Molecules and Alzheimer Disease Aβ Fibrils by Using MAS Solid‐State NMR Spectroscopy
por: Niu, Zheng, et al.
Publicado: (2020)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Current status and future perspective of radiopharmaceuticals in China
por: Hu, Ji, et al.
Publicado: (2021)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease
por: Sundaram, Guruswami SM, et al.
Publicado: (2015)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
por: Grimmer, Timo, et al.
Publicado: (2018)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Development and Validation of a PET/SPECT Radiopharmaceutical in Oncology
por: Pisaneschi, Federica, et al.
Publicado: (2021)

Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
por: Jamous, Mazen, et al.
Publicado: (2013)

Will extended field-of-view PET/CT depopulate the graveyard of failed PET radiopharmaceuticals?
por: de Vries, E. F. J., et al.
Publicado: (2022)

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review
por: Siebinga, Hinke, et al.
Publicado: (2022)

Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics
por: Kauffman, Nathan, et al.
Publicado: (2023)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019)

Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals
por: Evans, Brendan J., et al.
Publicado: (2020)

Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications()
por: Franquet, Elisa, et al.
Publicado: (2022)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
por: Nguyen, Anh Thu, et al.
Publicado: (2023)

Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions
por: Schumacher‐Schuh, Artur Francisco, et al.
Publicado: (2022)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis
por: Aasen, Synnøve Nymark, et al.
Publicado: (2021)

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
por: Szeto, Jennifer Y.Y., et al.
Publicado: (2016)

Therapeutics in paediatric genetic diseases: current and future landscape
por: Koh, Ai Ling, et al.
Publicado: (2023)

Cold Kit Labeling: The Future of (68)Ga Radiopharmaceuticals?
por: Lepareur, Nicolas
Publicado: (2022)

Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals
por: Sardaro, Angela, et al.
Publicado: (2022)

SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
por: Alqahtani, Fawaz F.
Publicado: (2023)

Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
por: Jeong, Young Jin, et al.
Publicado: (2023)

Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ucqb6on93qkpculobkdi6i8l1